Harvey Norman Limited (HNORY)
Harvey Norman Statistics
Share Statistics
Harvey Norman has 249.2M shares outstanding. The number of shares has increased by -18.92% in one year.
| Shares Outstanding | 249.2M |
| Shares Change (YoY) | -18.92% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 382.74M |
| Failed to Deliver (FTD) Shares | 64 |
| FTD / Avg. Volume | 96.97% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 16.36 and the forward PE ratio is null. Harvey Norman's PEG ratio is -0.47.
| PE Ratio | 16.36 |
| Forward PE | n/a |
| PS Ratio | 1.47 |
| Forward PS | n/a |
| PB Ratio | 1.28 |
| P/FCF Ratio | 11.66 |
| PEG Ratio | -0.47 |
Enterprise Valuation
Harvey Norman has an Enterprise Value (EV) of 30.83B.
| EV / Sales | 7.86 |
| EV / EBITDA | 36.82 |
| EV / EBIT | 44.91 |
| EV / FCF | 62.36 |
Financial Position
The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.51.
| Current Ratio | 2.31 |
| Quick Ratio | 1.61 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 2.72 |
| Debt / FCF | 4.61 |
| Interest Coverage | 3.25 |
Financial Efficiency
Return on Equity is 7.83% and Return on Invested Capital is 3.24%.
| Return on Equity | 7.83% |
| Return on Assets | 4.45% |
| Return on Invested Capital | 3.24% |
| Revenue Per Employee | $603.36K |
| Profits Per Employee | $54.22K |
| Employee Count | 6,500 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 3.46 |
Taxes
| Income Tax | 184.06M |
| Effective Tax Rate | 33.98% |
Stock Price Statistics
The stock price has increased by -18.73% in the last 52 weeks. The beta is 0.7, so Harvey Norman's price volatility has been higher than the market average.
| Beta | 0.7 |
| 52-Week Price Change | -18.73% |
| 50-Day Moving Average | 15.1 |
| 200-Day Moving Average | 14.89 |
| Relative Strength Index (RSI) | 9.64 |
| Average Volume (20 Days) | 66 |
Income Statement
In the last 12 months, Harvey Norman had revenue of 3.92B and earned 352.45M in profits. Earnings per share was 1.4.
| Revenue | 3.92B |
| Gross Profit | 1.99B |
| Operating Income | 361.21M |
| Net Income | 352.45M |
| EBITDA | 837.26M |
| EBIT | 594.58M |
| Earnings Per Share (EPS) | 1.4 |
Balance Sheet
The company has 273.47M in cash and 2.28B in debt, giving a net cash position of -2.01B.
| Cash & Cash Equivalents | 273.47M |
| Total Debt | 2.28B |
| Net Cash | -2.01B |
| Retained Earnings | 3.49B |
| Total Assets | 7.93B |
| Working Capital | 1.04B |
Cash Flow
In the last 12 months, operating cash flow was 686.53M and capital expenditures -192.16M, giving a free cash flow of 494.37M.
| Operating Cash Flow | 686.53M |
| Capital Expenditures | -192.16M |
| Free Cash Flow | 494.37M |
| FCF Per Share | 0.4 |
Margins
Gross margin is 50.76%, with operating and profit margins of 9.21% and 8.99%.
| Gross Margin | 50.76% |
| Operating Margin | 9.21% |
| Pretax Margin | 13.81% |
| Profit Margin | 8.99% |
| EBITDA Margin | 21.35% |
| EBIT Margin | 9.21% |
| FCF Margin | 12.61% |
Dividends & Yields
HNORY pays an annual dividend of $1.11, which amounts to a dividend yield of 5.23%.
| Dividend Per Share | $1.11 |
| Dividend Yield | 5.23% |
| Dividend Growth (YoY) | 16.73% |
| Payout Ratio | 99.62% |
| Earnings Yield | 6.11% |
| FCF Yield | 1.72% |
Analyst Forecast
Currently there are no analyst rating for HNORY.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 2.87 |
| Piotroski F-Score | 5 |